Original article by NewsNation: https://www.newsnationnow.com/health/glp-1-medication-addiction-treatment/amp/
As interest grows in GLP-1 medications like Ozempic and Mounjaro for weight loss, some doctors are discovering new potential uses beyond diabetes and obesity treatment. According to a recent report, these popular weight-loss drugs may also play a meaningful role in alcohol addiction and drug addiction recovery.
Dr. Steven Klein, an addiction specialist practicing in Pennsylvania and South Florida, is leading an emerging approach that uses Mounjaro injections as part of a GLP-1 addiction treatment program. More than 130 patients struggling with substance use disorders — including alcohol and opioid dependence — are currently enrolled in his program.
Klein says growing scientific evidence supports the idea that GLP-1 drugs can reduce cravings for addictive substances. Research from both human trials and animal studies suggests that medications like Ozempic and Mounjaro affect the brain’s reward system, potentially reducing the urge to drink or use drugs. He explains that these medications can help “quiet” the cravings triggered by substances such as alcohol, opioids, or even high-calorie foods.
Drawing from his own personal experience with food addiction, alcohol dependency, and drug misuse, Klein describes GLP-1 treatment as “transformative.” He believes the medications help patients feel balanced without relying on substances that typically activate the brain’s dopamine-driven reward pathways. This makes GLP-1 therapy a promising new tool for craving reduction and long-term addiction recovery.
It’s important to note that using GLP-1 medication for addiction remains off-label, as federal regulators have not yet approved these drugs for behavioral health or substance use disorders. However, many patients still qualify for medications like Mounjaro based on weight-related health conditions, allowing Klein to prescribe them legally while research continues.
The article also highlights recent efforts to lower the cost of weight-loss medications, which could expand access for people seeking GLP-1-based addiction treatment in the future.
To read the full original report, visit NewsNation:
https://www.newsnationnow.com/health/glp-1-medication-addiction-treatment/amp/